Abstract:Background Atherosclerotic disease has been present in the human population apparently from the beginning of time. However, it has only been in the 20th century that improvements in the control of infectious diseases have allowed the average life span to increase to the point where atherosclerosis has been able to affect the general population. By the middle of the 20th century, atherosclerosis had reached epidemic levels, and it is currently pandemic and increasing worldwide. Despite its growing significance to health care, we still know relatively little about the cellular basis for plaque genesis in the vessel wall. Current thinking holds that atherosclerosis is caused by an unchecked chronic inflammatory process involving the cells of the arterial wall and their interaction with LDL and various inflammatory cells. Considerable evidence suggests that the principal insults underlying atherogenesis are serum dyslipidemias and oxidative stress mediated primarily by oxidized LDL. However, just how these insults alter the cell biology of vascular cells and lead to the atherosclerotic phenotype is still under intense investigation. Moreover, recent clinical trials have provided evidence that certain classes of drugs, including newer calcium channel blockers (CCBs), can remodel the arterial smooth muscle cell (SMC) membrane and inhibit the progression of atherosclerotic disease. Methods This review summarizes our current thinking on atherogenesis in the arterial SMC and considers recent developments regarding alterations in the SMC membrane during the very early period of atherogenesis. We also discuss how certain CCBs might operate to produce atheroprotection. Results The SMC membrane becomes enriched in unesterified cholesterol soon after the development of serum hypercholesterolemia. With excess membrane cholesterol, the membrane becomes thicker and develops distinct cholesterol domains. These alterations in the membrane increase the permeability of SMC to calcium and induce a variety of alterations in SMC function that contribute to cellular atherogenic processes during plaque genesis. Amlodipine, a third-generation CCB, markedly inhibits the progression of lesions. The explanation of this novel action may lie in the effects of this drug on various potential cellular targets. Conclusions Evidence is accumulating that excess membrane cholesterol may contribute to the cellular defects responsible for the transformation of the SMC to the atherosclerotic phenotype. Amlodipine, which has membrane–remodeling properties, is emerging as an important atheroprotective drug. (Am Heart J 2001;141:S1-11.)

Effects of Dihydropyridine Calcium Channel Blockers on Oxidized Low-Density Lipoprotein Induced Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells

Effects of Captopril on Vascular Endothelial Cell Morphological and Functional Damages Induced by Oxidized Low Density Lipoproteins

Oxidized high-density lipoprotein induces the proliferation and migration of vascular smooth muscle cells by promoting the production of ROS.

[Effects of Icariin on Proliferation of Vascular Smooth Muscle Cell Induced by Ox-Ldl Via Impacting MAPK Signaling Pathway].

Oxidized low-density lipoprotein attenuated desmoglein 1 and desmocollin 2 expression via LOX-1/Ca(2+)/PKC-β signal in human umbilical vein endothelial cells.

Effects of Dehydroepiandrosterone on Expression of Vascular Cell Adhesion Molecule-1 Induced by Oxidized Low Density Lipoprotein in Vascular Smooth Muscle Cells

The Smooth Muscle Cell Membrane During Atherogenesis: A Potential Target for Amlodipine in Atheroprotection

Pharmacologic Treatment of Atherosclerosis: Beyond Lipid-Lowering Therapy.

Effect of Oxidated Low-Density Lipoprotein on Early Apoptosis of Vascular Smooth Muscle Cell

Ppar Gamma Inhibits Vsmc Proliferation And Migration Via Attenuating Oxidative Stress Through Upregulating Ucp2

Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.

Effects of Lysophosphatidylcholine on Monolayer Cell Permeability of Human Coronary Artery Endothelial Cells

Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation

Effects of Ox‐LDL on Number and Activity of Circulating Endothelial Progenitor Cells

The Inhibitory Effect of Oxidized Low Density Lipoprotein on the Expression of Caveolin-1 in Vascular Smooth Muscle Cell and Its Relation with Extracellular-signal Regulated Kinases 1/2

MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A.

Effects of Different Simple Triglycerides on Cell Fatty Acid Compositions, Proliferation-Related Protein, and Gene Expressions Induced by Oxidized-LDL in HUVSMCs.

XAV939 Inhibits Intima Formation by Decreasing Vascular Smooth Muscle Cell Proliferation and Migration Through Blocking Wnt Signaling

Effects of Docosahexaenoic Acid on Large-Conductance Ca2+-Activated K+ Channels and Voltage-Dependent K+ Channels in Rat Coronary Artery Smooth Muscle Cells

Effects of Suppressor of Cytokine Signalling-1 on Proliferation Induced by Oxidative Low-Density Lipoprotein in Vascular Smooth Muscle Cells

The Compatibility of Alisma and Atractylodes Affects the Biological Behaviours of VSMCs by Inhibiting the miR-128-5p/p21 Gene